z-logo
open-access-imgOpen Access
Targeting the tetraspanin CD81 reduces cancer invasion and metastasis
Author(s) -
Felipe VencesCatalán,
Ranjani Rajapaksa,
Chiung-Chi Kuo,
Caitlyn L. Miller,
Anderson Lee,
Vishnu C. Ramani,
Stefanie S. Jeffrey,
Ronald Levy,
Shoshana Levy
Publication year - 2021
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2018961118
Subject(s) - tetraspanin , cd81 , cancer metastasis , metastasis , cancer , cancer research , medicine , biology , virology , cell , hepatitis c virus , virus , genetics
Significance CD81 belongs to the evolutionary conserved tetraspanin family of proteins that form specialized membranal platforms that facilitate a vast array of cellular processes. However, little is known about the consequences of these molecular interactions under normal or pathological conditions. Tetraspanins have no known natural ligands, but ligation by some antibodies induces functional consequences. Here we show that engagement of CD81 with 5A6 halts tumor invasion in vitro and reduces breast cancer metastasis in vivo. Altogether, these finding highlight the role of CD81 in cancer progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom